We are live on ! Find out more
HLVX

HilleVax

Delisted

HLVX was delisted on the 16th of September, 2025.

61 hedge funds and large institutions have $436M invested in HilleVax in 2023 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 17 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 4

18% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 17

11% more funds holding

Funds holding: 5561 (+6)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

1% less capital invested

Capital invested by funds: $440M → $436M (-$3.96M)

11.61% less ownership

Funds ownership: 78.9%67.28% (-12%)

Holders
61
Holders Change
+6
Holders Change %
+10.91%
% of All Funds
0.97%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
11
Increased
20
Reduced
17
Closed
4
Calls
Puts
Net Calls
Net Calls Change

HLVX Hedge Fund Activity: Q1 2023 in Review

61 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in HilleVax (HLVX) for Q1 2023, worth a combined $436M — down 0.9% from $440M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new HLVX positions and 4 closed out — a net gain of 7 holders — while 20 added to existing stakes and 17 trimmed.

The largest buyer was Carlyle Group, opening a new position worth an estimated $29.4M. The largest seller was Vanguard Group, cutting an estimated $3.36M.

  • 61 institutional investors held HilleVax (HLVX) as of Q1 2023, up from 55 in Q4 2022.
  • Funds reported $436M of HilleVax stock for Q1 2023, down 0.9% quarter-over-quarter.
  • 11 funds opened new HilleVax positions in Q1 2023 and 4 closed out, a net change of +7 holders.
  • The largest HilleVax buyer in Q1 2023 was Carlyle Group, an estimated $29.4M added.
  • The largest HilleVax seller in Q1 2023 was Vanguard Group, an estimated $3.36M sold.

Based on aggregated 13F filings for Q1 2023.